Merck KGaA (OTCMKTS:MKGAF – Get Free Report) is anticipated to announce its resultson Wednesday, May 13th. Analysts expect the company to announce earnings of $2.27 per share and revenue of $5.8536 billion for the quarter.
Merck KGaA Stock Down 0.8%
MKGAF opened at $131.64 on Wednesday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average price of $133.46 and a 200-day moving average price of $139.41. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $159.34. The stock has a market capitalization of $17.01 billion, a price-to-earnings ratio of 20.10 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
